Clinical Relevance of Intrahepatic Hepatitis B Virus DNA in HBsAg-negative HBcAb-positive Patients Undergoing Hematopoietic Stem Cell Transplantation for Hematological Malignancies
- 15 July 2006
- journal article
- letter
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (1) , 141-2
Abstract
Hepatitis flare-up due to hepatitis B virus (HBV) is a well-recognized complication associated with chemotherapy. Data on the clinical impact of HBV DNA in liver tissue of HB-surface antigen (sAg)-negative patients undergoing immunosuppression are scantyKeywords
This publication has 9 references indexed in Scilit:
- A long-term follow-up study on hepatitis B surface antigen–positive patients undergoing allogeneic hematopoietic stem cell transplantationBlood, 2005
- Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcomeBlood, 2004
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infectionGastroenterology, 2004
- Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary taleBlood, 2002
- Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differencesJournal of Virological Methods, 2002
- Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAGJournal of Hepatology, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Southern-blot analysis and simultaneous In Situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver diseaseHepatology, 1993
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyGastroenterology, 1991